Discover how early CMC, process optimization, and formulation strategy drive scalable, commercially viable drugs.

Early on, the drug substance (DS) manufacturer will provide a wealth of preliminary characterization data. And if the drug is active in early nonclinical and preclinical testing, a larger quantity of ...

The global COVID-19 pandemic highlighted the necessity of accelerating various stages of drug development, lowering drug candidate attrition rates, and establishing reliable testing processes to ...

In the fast-paced world of drug development, time is often the most precious commodity. For biotech companies working on oral ...

Moderna has tapped Swedish long-acting drug formulation company Nanexa to improve the delivery of up to five injectable therapies. The heavily back-loaded deal will see Moderna hand over just $3 ...

When it comes to developing a new medicine, designing the active compound is only half the battle. “Many potential therapeutic compounds are hydrophobic—oily—so they’re not very stable in aqueous ...

Patients with some cancers, autoimmune diseases, and metabolic disorders often endure time-consuming intravenous (IV) infusions to receive the best protein-based treatments available. Because these ...

TOKYO--(BUSINESS WIRE)--Elix, Inc., an AI drug discovery company with the mission of “Rethinking Drug Discovery” (CEO: Shinya Yuki/Headquarters: Tokyo, Japan; hereinafter referred to as “Elix”) has ...

The structure of a kinase enzyme inhibitor that could become a next-generation drug for melanoma made its public debut this week (Nature, DOI: 10.1038/nature09454). The unveiling comes on the heels of ...